Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage: Technical note

Journal of Neurosurgery

Volumn 110, Issue 5, 2009, Pages 939-942

  Gazzeri, Roberto ^a,c   Galarza, Marcelo ^a   Neroni, Massimiliano ^a   Alfieri, Alex ^b   Esposito, Stefano ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b UNIVERSITY OF BERN   (Switzerland)

^c NONE   (Italy)

Author keywords

Hemostasis; Hemostatic sealant; Intracerebral hemorrhage; Spontaneous hematoma

Indexed keywords

HEMOSTATIC AGENT; SEALANT; FLOSEAL MATRIX; GELATIN SPONGE;

ARTICLE; BIOCOMPATIBILITY; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CRANIOTOMY; HEMOSTASIS; HUMAN; MINIMALLY INVASIVE SURGERY; PATIENT SAFETY; PRIORITY JOURNAL; SKIN INCISION; HEMATOMA; INJECTION; METHODOLOGY;

CEREBRAL HEMORRHAGE; CRANIOTOMY; GELATIN SPONGE, ABSORBABLE; HEMATOMA; HEMOSTATICS; INJECTIONS;

EID: 66849099908     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.8.JNS17642     Document Type: Article

References (9)

1. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1-5, 1997
2. Ellegala DB, Maartens NF, Laws ER Jr: Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 51:513-516, 2002
3. Mendelow AD, Gregson BA, Fernandez HM, Murray GD, Teasdale GM, Hope DT, et al: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365:387-397, 2005
4. Montes JM, Wong JH, Fayad PB, Awad IA: Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma: protocol and preliminary experience. Stroke 31:834-840, 2000
5. Payner T, Vega F, Taw J, Polidoro DP, Soria ML, Reich CJ: Floseal matrix hemostatic sealant. Safety, biocompatibility and biodegradation brain implantation study in rats. Fusion Medical Technologies, Inc. Study Number P01-050. Report Date 04-2003
6. Renkens KL Jr, Payner T, Leipzig TJ, Feuer H, Morone MA, Koers JM, et al: A multicenter, prospective, randomized trial evaluating a new hemostatic agent in spinal surgery. Spine 26: 1645-1650, 2001
7. Thiex R, Tsirka SE: Brain edema after intracerebral hemorrhage: mechanisms, treatment options, management strategies, and operative indications. Neurosurg Focus 22(5):E6, 2007
8. Wagner KR, Xi G, Hua Y, Zuccarello M, de Courten-Myers GM, Broderick JP, et al: Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. J Neurosurg 90:491-498, 1999
9. Xi G, Keep RF, Hoff JT: Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol 5:53-63, 2006